QQ客服 官方微博 反馈留言

	Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy
	Yang, Heng; Ma, Yuting; Chen, Guo; Zhou, Heng; Yamazaki, Takahiro; Klein, Christophe; Pietrocola, Federico; Vacchelli, Erika; Souquere, Sylvie; Sauvat, Allan
	2016
卷号	5期号:6页码:e1149673
关键词	ATP chemotherapy cytotoxic T cells dendritic cells HMGB1 Necroptosis Tumor immunogenicity
ISSN号	2162-402X
DOI	10.1080/2162402X.2016.1149673
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6382094
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Yang, Heng,Ma, Yuting,Chen, Guo,et al. Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy[J],2016,5(6):e1149673.
APA	Yang, Heng.,Ma, Yuting.,Chen, Guo.,Zhou, Heng.,Yamazaki, Takahiro.,...&Kroemer, Guido.(2016).Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy.,5(6),e1149673.
MLA	Yang, Heng,et al."Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy".5.6(2016):e1149673.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。